Lunit Inc. develops and provides AI based software solutions for cancer screening/diagnosis and treatment. It offers AI solution for chest X-ray and mammography, as well as AI-powered biomarker for immune phenotyping and PD-L1 quantification for immunotherapy. The company was incorporated in 2013 and is based in Seoul, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $31.10 | N/A |
Market Cap | $885.50M | N/A |
Shares Outstanding | 28.48M | N/A |
Employees | 259.00 | N/A |